How to Check an FDA Warning Letter for a Peptide Supplier

A warning letter from the U.S. Food and Drug Administration is one of the few public, dated, primary-source records that exist about a research peptide supplier. It is also one of the most misread. This guide explains where the letters live, how to search for a company, what a letter does and does not establish, and exactly how this site records one when it finds it.

Where the FDA publishes letters

The FDA posts warning letters on fda.gov under Inspections, Compliance, Enforcement and Criminal Investigations, then Compliance Actions and Activities, then Warning Letters. The page is a searchable, sortable database. Each row shows the posting date, the letter issue date, the company name, the issuing office, the subject and a response status. Clicking a row opens the full letter as a web page, with the recipient’s address, the regulatory citations and the FDA’s requested actions.

Two details about timing matter. The issue date is when the letter was sent. The posting date is when it appeared in the database, and the gap is often several weeks. A letter can exist before it is public. Second, the database is not the only place a letter can surface; some are first reported by law firms and trade press, and a few are referenced in FDA press releases before they are posted.

Related but distinct documents also exist. Untitled letters raise concerns the agency considers less serious and are not always posted. Letters sent to online sellers about unapproved products are sometimes styled differently and filed under a particular office. Closeout letters, when issued, record that the FDA considers the matters in a prior warning letter addressed. Import alerts and recalls are separate systems with their own databases.

How to search by company

1. Open the Warning Letters database on fda.gov.
2. Type the company name into the search box. Start with the name as it appears on the supplier’s website footer or terms page, which is often a legal entity name different from the brand.
3. Repeat with the brand name and with the domain name without the extension. Letters are filed under the addressed entity, and online sellers are sometimes addressed by domain.
4. Check the issuing office and subject columns. Letters relevant to this category usually come from the Center for Drug Evaluation and Research or a district office, with subjects referring to unapproved products, labeling or marketing.
5. Open the letter. Confirm the recipient’s address or domain matches the supplier you are checking. Companies with similar names exist, and lookalike domains are common in this category.
6. Note the issue date, the posting date and the URL. Those three items are what we store.

If the search returns nothing, try alternate spellings and any former names listed in the supplier’s about page or in our aka field. If the supplier is outside the United States, a letter may still exist if it sold into the U.S. market, and the agency’s address block will show the foreign address.

What a warning letter is

A warning letter is a formal notice that the FDA has observed what it considers violations of the laws it enforces, most often the Federal Food, Drug, and Cosmetic Act. The letter describes the observations, cites the provisions involved, and asks the company to respond in writing, typically within 15 working days, explaining how it has corrected the problems or why it disagrees. The letter states that failure to correct may lead to further action, which can include seizure, injunction or import refusal.

In this category the observations are usually about how products are described and sold: statements on product pages, labeling, and the relationship between research-use disclaimers and the surrounding marketing. We do not repeat the claims cited in any letter; the letter itself is linked from the supplier page for readers who want the text.

What a letter does not establish

A warning letter is a regulatory communication, not a court finding. It means the agency believes, based on what it reviewed, that violations occurred. The company may dispute it. The letter does not by itself prove that any product was impure, mislabeled as to content or unsafe. It makes no statement about certificates of analysis unless the letter says so.

A letter does not mean the company has been shut down. Many recipients continue to operate. Some change the wording on their sites, some respond and receive a closeout letter, some close and reappear under a new name, and some ignore the letter. The response status column in the database shows whether a response was received, but the FDA does not publish the content of most responses.

Equally, the absence of a letter does not establish compliance. The FDA issues letters to a small fraction of sellers in any category, and enforcement priorities shift. A supplier with no letter is a supplier with no letter, and nothing else can be inferred.

How this site records a letter

Step	What we do	Where it shows
Find	Search the FDA database by legal name, brand and domain during data collection and re-checks	sources list on the supplier record
Store	Record the issue date and the fda.gov URL	trust.fda_warning_letter: {date, url}
Flag	Set the supplier’s status	status: fda_warning
Score	Apply a heavy penalty in the track record factor	Factor scores on the supplier page
Disclose	State the letter date and link to it, in neutral wording, on the supplier page	Body of /vendors/<slug>/
List	Add the supplier to the warnings page	/warnings/

The wording on the supplier page is deliberately flat: the FDA issued a warning letter dated such-and-such concerning the matters the letter describes, with a link. We do not editorialize about the company’s response, and we do not describe the cited claims. If a closeout letter is later posted we add it to the record and the supplier page notes it, but the original letter stays in the record because it is part of the public history.

We record only letters we can link to on fda.gov. A letter reported by a third party but not yet posted is noted in the notes field as unconfirmed until the primary source is available. A letter addressed to a different legal entity with a similar name is not attributed to a supplier unless the letter’s address or domain matches.

Checking our work

Every supplier page with a letter links directly to the fda.gov document. Open it and confirm the recipient. If you believe a letter is misattributed, or you have found one we have not recorded, send the fda.gov URL through the contact page; the correction route is described on the methodology page and in our guide to how we collect supplier facts. The current list is at warnings, and the broader set of signals we record is in the red flags guide.

Summary

FDA warning letters are public, dated and searchable by company on fda.gov. A letter tells you the agency observed violations and asked for a response; it does not tell you a company is closed, that its products failed any test, or that a company without a letter is compliant. Search under the legal name, brand and domain, confirm the address, and read the primary document. On this site the date and link are stored with the supplier, the status is flagged, the score is penalized and the letter is disclosed in plain words.